Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2006
10/19/2006US20060233709 Method for identifying novel treatments of inflammatory disease in the gut
10/19/2006US20060233707 Process for producing an injectable medicament preparation
10/19/2006US20060233704 Prochelator for the preparation of radiometal labeled molecules having improved biological properties
10/19/2006CA2582231A1 Steroid analogs and uses
10/18/2006EP1711618A1 Methods for detecting markers associated with endometrial disease or phase
10/18/2006EP1711211A1 Ultrasound contrast agents for molecular imaging
10/18/2006EP1711203A1 Targeted atherosclerosis treatment
10/18/2006EP1711052A1 Mouse model for psoriasis and psoriatic arthritis
10/18/2006EP1523337B1 Imaging method and device for carrying out said method
10/18/2006EP0914165B1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms
10/18/2006EP0806968B1 Diagnostic imaging contrast agents with extended blood retention
10/18/2006EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006CN1849142A 2'-branched nucleosides and flaviviridae mutation
10/18/2006CN1849136A Cancerous disease modifying antibodies
10/18/2006CN1847285A Polyoxyethylene ligand containing coupler and its synthesis process
10/18/2006CN1279982C Ultrasonic microbubble contrast medium containing gene
10/17/2006USRE39357 Medicine for clogging blood vessels of eye fundus
10/17/2006US7122714 Animal model for use in the diagnoois and treatment of prostate cancer
10/17/2006US7122635 Method and composition for angiogenesis inhibition
10/17/2006US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/17/2006US7122195 Mutant mycobacteria for use in therapy
10/17/2006US7122194 Mixture of polypeptide with carrier
10/17/2006US7122173 A compound having slowly-deactivating A-type K+ channel opening activity such as N-(5,5-dioxido-10-oxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide
10/17/2006US7122172 Methods and compositions for targeted drug delivery
10/17/2006US7122133 Finely particulate functional metal and finely particulate functional semiconductor each with dispersion stability and process for producing the same
10/17/2006CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/17/2006CA2087902C Liposome compositions of porphyrin photosensitizers
10/12/2006WO2006107950A2 Method for monitoring early treatment response
10/12/2006WO2006107098A1 Glycerol ester derivative having metal chelate structure
10/12/2006WO2006106983A1 Radiotherapy enhancer
10/12/2006WO2006106752A1 Noninvasive analysis method
10/12/2006WO2006106558A2 Use of nothobranchius furzeri as a model system for the characterisation of genes that control ageing
10/12/2006WO2006106544A2 Use of nothobranchius furzeri as a model system for the characterization of drugs that control ageing
10/12/2006WO2006106513A2 New core and core-shell nanoparticles containing iodine for x-ray imaging
10/12/2006WO2006106383A1 Photosensitizers and mri enhancers
10/12/2006WO2006060393A3 Biological systems analysis
10/12/2006WO2006052566A3 Gpr41 and modulators thereof for the treatment of insulin-related disorders
10/12/2006US20060228554 Precipitating nano-sized cores from reagents dissolved in the aqueous compartment of a water-in-oil microemulsion; silica coated; as dye-doped particles, "pigmentless" pigment particles, metal particles, semiconductor particles, magnetic particles, and drug molecule particles
10/12/2006US20060228304 Liquid embolisate
10/12/2006US20060228303 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen
10/12/2006US20060228302 Pproducing a tumorigenic mouse cell by introducing into the cell containing a recombinant oncogene operably linked to an inducible promoter, a recombinant gene of interest that functionally complements the oncogene and restores tumorigenicity without expression of the inducible recombinant oncogene
10/12/2006US20060228301 Methods and compositions for determining targeted drug sensitivity and resistance in a cancer subject
10/12/2006US20060228298 Imaging and selective retention of phospholipid ether analogs
10/12/2006CA2603524A1 Photosensitizers and mri enhancers
10/12/2006CA2602335A1 Non-degradable low swelling, water soluble radiopaque hydrogels
10/11/2006EP1710265A1 Radiopaque polymers for circuit board assembly
10/11/2006EP1709959A1 Reagent for lacrimation examination and method of lacrimation examination
10/11/2006EP1708763A1 Methods, compositions, and devices for embolizing body lumens
10/11/2006EP1708732A2 Synthetic hla binding peptide analogues and uses thereof
10/11/2006EP1708566A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds
10/11/2006CN1845988A Method for immunotherapy of tumors
10/11/2006CN1844399A Construction method for mfg12-mouse fibroleukin antisense plasmid and its pharmaceutical use
10/11/2006CN1278740C Contrast agent and improved contrast agent thereof
10/11/2006CN1278675C Granular body containing polydroxy alkoxide acid ester and its preparation method
10/10/2006USRE39337 Nude mouse model for human neoplastic disease
10/10/2006US7119069 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
10/10/2006US7118919 Glucose for analysis of diabetes, Insulin resistance and metabolism
10/10/2006US7118731 Antitumor agents; anticancer agents; viricides; nucleoside derivative
10/10/2006US7118730 Quinoline derivative as diagnostic probe for disease with tau protein accumulation
10/10/2006CA2268968C Iminochlorin aspartic acid derivatives
10/10/2006CA2237056C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
10/05/2006WO2006105038A2 Methods of altering gene expression and methods of treatment utilizing same
10/05/2006WO2006103684A2 Device, system and method for in vivo magnetic immunoassay analysis
10/05/2006WO2006103677A2 Exogenous markers for oxidative stress
10/05/2006WO2006103639A2 Methods and reagents for identifying/isolating t regulatory (treg) cells and for treating individuals
10/05/2006US20060225143 Animal exhibiting ptsd-like behavior, per pct rule 4.3
10/05/2006US20060223127 Serum biomarkers in lung cancer
10/05/2006US20060222697 Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
10/05/2006US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/05/2006US20060222596 Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
10/05/2006US20060222595 Nanoparticles for therapeutic and diagnostic applications
10/05/2006US20060222594 Smart magnetic nanosphere preparation and manufacturing method thereof
10/05/2006US20060222593 Peptide-chelate conjugates
10/05/2006US20060222592 Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
10/05/2006US20060222591 Method for monitoring early treatment response
10/05/2006US20060222590 Directed complementation
10/05/2006US20060222589 Directed complementation
10/05/2006DE19948651B4 Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung Para- and diamagnetic perfluorinated compounds containing pharmaceutical formulations, their preparation and use
10/05/2006DE10231799B4 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the representation of intravascular thrombi
10/05/2006CA2602120A1 Methods of altering gene expression and methods of treatment utilizing same
10/04/2006EP1706355A2 Method for enriching hyper-polarized atom nuclei and method for carrying out said method
10/04/2006EP1706158A1 Medical devices visible under magnetic resonance imaging
10/04/2006EP1534351B1 Embolization
10/04/2006EP1185309B1 Liquid gel composition for mapping a breast milk duct prior to surgical excision of the duct or other breast tissue
10/04/2006EP1141359B1 Non-invasive evaluation of physiological response in a mammal
10/04/2006CN1840531A Porphyrin-based compounds for tumor imaging and photodynamic therapy
10/04/2006CN1840206A Model construction of human flora-associated piggy and molecular method for detecting flora in intestine tract of baby pig
10/04/2006CN1840205A Transgene mouse model of poly glumine disease, its culturing method and medicine for treating the disease
10/04/2006CN1839806A Methods for in vivo delivery of biologics and compositions useful therefor
10/03/2006US7115583 Microbubble compositions and methods for oligonucleotide delivery
10/03/2006US7115392 Polynucleotides encoding human vascular endothelial growth factor 2
10/03/2006US7115385 Media and methods for cultivation of microorganisms
10/03/2006US7115361 Detection of CD8+ T cell responses to M. tuberculosis
10/03/2006CA2275419C Mucosal administration of substances to mammals
10/03/2006CA2205906C In-vivo diagnostic process by near infrared radiation
09/2006
09/28/2006WO2006102337A2 L-arginine and zinc supplementation for repair of intestinal epithelial cell injury
09/28/2006WO2006102307A2 Target specific nanoparticles for enhancing optical contrast enhancement and inducing target-specific hyperthermia
09/28/2006WO2006101503A2 Method for screening agents against human prostate disease
09/28/2006WO2006100305A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging
09/28/2006WO2006083378A3 IN VIVO MONITORING OF β-AMYLOID PLAQUES AND NEUROFIBRILLARY TANGLES